{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T01:16:22Z","timestamp":1784337382659,"version":"3.55.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1097\/inf.0000000000001447","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T11:41:29Z","timestamp":1480678889000},"page":"435-437","source":"Crossref","is-referenced-by-count":14,"title":["Safety of Infliximab Following Live Virus Vaccination in Kawasaki Disease Patients"],"prefix":"10.1097","volume":"36","author":[{"given":"Aaron M.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane C.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana H.","family":"Tremoulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20210202","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","article-title":"A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.","volume":"324","author":"Newburger","year":"1991","journal-title":"N Engl J Med"},{"key":"R2-27-20210202","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/00006454-199812000-00009","article-title":"Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US\/Canadian Kawasaki Syndrome Study Group.","volume":"17","author":"Burns","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"R3-27-20210202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jpeds.2007.12.021","article-title":"Resistance to intravenous immunoglobulin in children with Kawasaki disease.","volume":"153","author":"Tremoulet","year":"2008","journal-title":"J Pediatr"},{"key":"R4-27-20210202","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0090-1229(88)90088-8","article-title":"Peripheral blood monocyte\/macrophages and serum tumor necrosis factor in Kawasaki disease.","volume":"48","author":"Furukawa","year":"1988","journal-title":"Clin Immunol Immunopathol"},{"key":"R5-27-20210202","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jpeds.2004.12.022","article-title":"Infliximab treatment for refractory Kawasaki syndrome.","volume":"146","author":"Burns","year":"2005","journal-title":"J Pediatr"},{"key":"R6-27-20210202","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpeds.2008.06.011","article-title":"Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease.","volume":"153","author":"Burns","year":"2008","journal-title":"J Pediatr"},{"key":"R7-27-20210202","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(13)62298-9","article-title":"Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.","volume":"383","author":"Tremoulet","year":"2014","journal-title":"Lancet"},{"key":"R9-27-20210202","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"R10-27-20210202","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrrheum.2009.279","article-title":"Tumor necrosis factor blockade and the risk of viral infection.","volume":"6","author":"Kim","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"R11-27-20210202","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","article-title":"Case report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn\u2019s disease.","volume":"4","author":"Cheent","year":"2010","journal-title":"J Crohns Colitis"},{"key":"R12-27-20210202","first-page":"1","article-title":"ACIP): use of vaccines and immune globulins for persons with altered immunocompetence.","volume":"42","year":"1993","journal-title":"MMWR Recomm Rep"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000001447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:13:21Z","timestamp":1620954801000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201704000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001447","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}